Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Brainstorm Cell (NQ: BCLI )

0.2090 +0.0041 (+2.00%)
Streaming Delayed Price Updated: 3:41 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,051,590
Open 0.2199
Bid (Size) 0.2080 (2)
Ask (Size) 0.2099 (4)
Prev. Close 0.2049
Today's Range 0.2050 - 0.3000
52wk Range 0.1693 - 4.560
Shares Outstanding 45,015,800
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Blue Apron Holdings, Inc. (NASDAQ: APRN) climbed 133.5% to $12.82 after the company announced an agreement to be acquired by Wonder Group for $13 per share. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga

Performance

YTD
-87.49%
-87.49%
1 Month
-88.06%
-88.06%
3 Month
-89.55%
-89.55%
6 Month
-91.64%
-91.64%
1 Year
-95.00%
-95.00%

More News

Read More
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation – BCLI
From The Rosen Law Firm, P.A.
Via Business Wire
Brainstorm Cell's Earnings: A Preview
Via Benzinga
Nasdaq Rises Over 100 Points; Accenture Shares Fall After Q4 Results
Via Benzinga
Topics Stocks
Exposures US Equities
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Crude Oil Moves Lower; CarMax Posts Downbeat Earnings
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Dow Rises 80 Points; US Jobless Claims Edge Higher
Via Benzinga
Topics Stocks
Exposures US Equities
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
FDA Advisory Panels Gives Thumbs Down To BrainStorm's Lead Therapy
Via Benzinga
Exposures Product Safety
Why Galecto Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Gold Moves Lower; TransCode Therapeutics Shares Surge
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Nasdaq Turns Higher; SCYNEXIS Shares Plunge
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Neurodegenerative Disease-Focused Brainstorm Cell Therapeutics Stock Plunging Today?
Via Benzinga
Exposures Product Safety
Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
U.S. Stocks Open Lower; Chicago Fed Index Falls In August
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Roth MKM Analyst Projects An Impressive Price Target Of $15 Over The Next 12 Months For BioRestorative Therapies (NASDAQ: BRTX), Says "Low Valuation Undeserved"
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.